Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FRUZAQLA CAPSULE 5MG - HSA Drug Approval Details

Approvals/HSA/FRUZAQLA CAPSULE 5MG

Approved

THERAPEUTIC

FRUZAQLA CAPSULE 5MG

STA Pharmaceutical Switzerland SA🇸🇬 Health Sciences Authority

Approval Date: Oct 17, 2024
Approval ID: 6b662a257f014e38
Company: STA Pharmaceutical Switzerland SA
Type: Therapeutic

Approval Details

Approval Id: 6b662a257f014e38
Drug Name: FRUZAQLA CAPSULE 5MG
Product Name: FRUZAQLA CAPSULE 5MG
Approval Number: SIN17113P
Approval Date: 2024-10-17
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: L01EK04
Pharma Manufacturer Name: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
Company Detail Path: /organization/cb7f295348c72082/takeda-pharmaceuticals-asia-pacific-pte-ltd

Active Ingredients

Fruquintinib

5mg

Fruquintinib

5mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 17, 2024

Approval ID

6b662a257f014e38

Type

Therapeutic

Back to HSA Approvals